Stay updated on AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.

Latest updates to the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page
- Check7 days agoChange DetectedVersion 2 (2023-09-17) updated recruitment status and related study details. Version 3 (2025-03-04) updated recruitment status, study status, and contacts/locations.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a prominent government-status notice and a version upgrade to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference13%

- Check36 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check50 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. There are no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.8%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.8%

- Check64 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference9%

Stay in the know with updates to AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.